Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture.
about
Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosisHepatic Stellate Cells and microRNAs in Pathogenesis of Liver FibrosisMicroRNAs as Biomarkers for Liver Disease and Hepatocellular CarcinomaPharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic FibrosisMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsMicroRNA-mediated interactions between host and hepatitis C virusMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyIsolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations.MicroRNA function in the profibrogenic interplay upon chronic liver disease.microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virusmiR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A.Complex interactions between microRNAs and hepatitis B/C viruses.The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesisMicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature.A computational approach to identifying gene-microRNA modules in cancer.MicroRNAs: Role in Hepatitis C Virus pathogenesisCirculating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs.MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresiaActivation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan.Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemiaMicroarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries.MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cellsThe Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study.Regulation of viral oncogenesis by microRNAs.High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.Hepatitis C virus infection, microRNA and liver disease progressionAchieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.RNA viruses and microRNAs: challenging discoveries for the 21st century.Apoptosis and necrosis in the liverHepatitis C Virus and HIV Type 1 Co-Infection.miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.A microRNA network regulates proliferative timing and extracellular matrix synthesis during cellular quiescence in fibroblasts.MicroRNAs in Liver Disease: Bench to Bedside.MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacyMicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection?The role of microRNAs in hepatitis C virus replication and related liver diseases.MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice.MicroRNAs, HIV and HCV: a complex relation towards pathology.
P2860
Q21560965-602EBDB0-0234-436C-9028-4F6300DFE652Q26752932-E62F6C6D-07DE-4A93-84A3-D8A38815FDC9Q26765476-5D528B63-2925-4CCD-87D7-D35402404F94Q26768588-285E0122-BD5D-4C21-87B0-8232B404AF92Q26773183-A468E0C1-66BB-4536-AF29-97661F7CB2CBQ26773254-3CA7F318-CA63-4FFB-A668-5DF42A8D56C5Q27015778-67CD96C3-FCC1-4A9D-97F5-DB02261AA808Q27303171-FE97FDBA-33FE-46AD-AF2B-49DAD217F38CQ33907481-93BE37E8-C428-42BA-A879-E6DCF3911237Q34163429-C7733147-0467-4E8C-9CBD-BF9D1244A72EQ34179800-1B1B244F-F8C6-4850-A118-A1CA58D79759Q34302987-C8715DC8-293F-4DFE-9CA7-023C71359F0BQ35055339-3FE108F8-BA49-4C3D-A675-84EC2F1B7F9CQ35202304-8CC773F6-849E-4339-9502-5D443FD2E4C9Q35547227-C985EFA7-332F-4219-B007-BF89A8728C4AQ35606627-870741BA-D39A-4129-8798-EB2326749B70Q35628167-436C14EC-CD80-414B-8B2E-A8DE47B8240BQ35650384-901C0225-7F72-4A2F-A29E-E9A6254EB11CQ35690705-B3B0B673-12C0-4ADE-B8E9-EBBFDE6351CFQ35754727-418E27CB-994E-46A7-A9AA-969FE63E8A85Q35819563-C79BA7E0-FA87-45F5-AD3F-45C15589BCB2Q36515468-6A6EC4F2-F2B6-4C66-A719-C48125C2E6C5Q36743589-D961633B-8BC3-47CC-95A3-4C220824FA74Q36759971-49167C1A-2C8E-4B49-A4AE-AB44D77953BEQ36969738-2C92FFD8-00D0-4C5B-827A-2959197D5713Q36997713-F662F326-9F51-4F24-89DA-ADF0E83C4F7CQ37123557-57AAF8FB-6911-4FE9-979D-79D2EF40D3A7Q37196517-F4E96306-19E6-4C29-884A-E46DB252E448Q37252581-CE8F3B8D-3DA0-4180-B899-F005B49D4325Q37346014-0927107F-BEDE-40AC-AAB4-9330C800A2D2Q37403072-66DFE27F-4753-4BE2-AE2F-0F329D064DB5Q37481988-213D913C-AE8A-43BE-978E-C572F868DBE1Q37578279-BBB8D8B4-1AB7-4828-9224-E4FCD9A8357BQ37584479-440AEDE2-E35B-476D-A6D7-24F6DEB564D7Q37613598-41E4D05C-EEF7-4CBF-B2D5-227091673601Q38018170-4A4925DA-DEF3-4EA2-94E3-7B6651D1B71FQ38193005-8A52A039-78D0-4C24-AF6E-F88D40CB805CQ38215700-82EC25BC-4B66-4593-8C8F-4AE85B7F2F3EQ38754395-EA688E56-9E59-4872-9BE7-36B4212F136BQ38802349-AFD50440-A30A-4752-ADAC-2FC401990682
P2860
Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hepatitis C virus infection an ...... C viral abundance in culture.
@ast
Hepatitis C virus infection an ...... C viral abundance in culture.
@en
type
label
Hepatitis C virus infection an ...... C viral abundance in culture.
@ast
Hepatitis C virus infection an ...... C viral abundance in culture.
@en
prefLabel
Hepatitis C virus infection an ...... C viral abundance in culture.
@ast
Hepatitis C virus infection an ...... C viral abundance in culture.
@en
P2093
P2860
P356
P1476
Hepatitis C virus infection an ...... s C viral abundance in culture
@en
P2093
Anton P McCaffrey
Benjamin Kong
Christopher B Burge
Kathy Keck
Kyle E Brown
Rebecca T Marquez
Sarmistha Bandyopadhyay
Warren N Schmidt
Yulei Wang
P2860
P304
P356
10.1093/INFDIS/JIR186
P407
P577
2011-06-01T00:00:00Z